CCM
ALXN

Cinctive Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Cinctive Capital Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29,399
Closed -$5.4M – 718
2021
Q2 		$5.4M Sell
29,399
-49,917
-63% -$8.57M 0.29% 118
2021
Q1 		$12.1M Buy
79,316
+454
+0.6% +$70.2K 0.77% 15
2020
Q4 		$12.3M Sell
78,862
-22,802
-22% -$2.93M 1.04% 7
2020
Q3 		$11.6M Buy
101,664
+32,701
+47% +$3.53M 1.07% 6
2020
Q2 		$7.74M Buy
68,963
+22,618
+49% +$2.4M 0.93% 13
2020
Q1 		$4.16M Sell
46,345
-16,955
-27% -$1.66M 0.97% 29
2019
Q4 		$6.85M Buy
+63,300
New +$6.77M 0.74% 39

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return